USA Medical Coding Market

USA Medical Coding Market


USA Medical Coding Market: Global Industry Analysis 2015-2022 and Opportunity Assessment 2023-2033

A recent market study published by FMI on USA Medical Coding offers a global industry analysis for 2015-2022 and opportunity assessment for 2023-2033. The study offers a comprehensive assessment of the most important market dynamics. After conducting thorough research on the historical and current growth parameters, the growth prospects of the market are obtained with maximum precision.

Market Segmentation

By Clinical Specialties:
  • Emergency Medicine
  • Diagnostic Pathology Services
  • Diagnostic Imaging
  • Radiology Imaging
  • Interventional Radiology
  • Nuclear Medicine
  • Inpatient Treatment
  • Radiology Imaging
  • Interventional Radiology
  • Nuclear Medicine
  • Anaesthesia and Critical Care
  • Cardiology & Cardiac Surgery
  • Gastroenterology & Hepatology
  • Obstetrics and Gynecology
  • Nephrology
  • Urology
  • Neurology & Neurosurgery
  • General Surgery
  • Orthopedics
  • Spinal and Pulmonology
  • Reproductive Medicine
  • Rheumatology
  • Dental Sciences & Cranio-Maxillo Facial Surgery
  • Oncology
  • Diabetology & Endocrinology
  • Pediatrics & Neonatology
  • Psychiatry & Clinical Psychology
  • Organ Transplant
  • Outpatient Treatment & Diagnostics
  • Ophthalmology
  • Dermatology
  • ENT
  • Clinical Nutrition
  • Ambulatory Surgery
  • Physician Office Visits
  • Ancillary Services
  • Observation Services
  • Others
By Service:
  • In-house
  • Outsourced
By End User:
  • Enterprise Therapy Practices
  • Hospitals
  • Ambulatory Surgical Centers
  • Cancer Research Institutes
  • Long Term Care Centers
  • Small Therapy Practices
  • Specialty Clinics
  • Independent Physician Practices
  • Diagnostic & Reference Laboratories
  • Diagnostic Imaging Centers
  • Educational & Research Institutes
  • Healthcare Payers
  • EMS Services
  • Health Services
By Region:
  • Northeast USA
  • Midwest USA
  • Southeast USA
  • Southwest USA
  • West USA
Report Chapters

Executive Summary

The executive summary of the USA Medical Coding Market includes the global market outlook, demand side trends, supply side trends and also include FMI analysis and recommendations of Vehicle Radar Test System.

Chapter 01 - Market Overview

Readers can find the detailed segmentation and definition of the USA Medical Coding Market in this chapter, which will help to understand basic information about Vehicle Radar Test System. This section also highlights the market scope, taxonomy and limitations which help the reader understand the market coverage of USA Medical Coding Market report.

Chapter 02 - Market Background

This chapter includes detailed analysis of the By Clinical Specialties processing methods overview, consumer buying patterns & tendencies and policy developments and regulatory scenario. It also includes in depth analysis of macro-economic factors and covers topics like global GDP growth outlook, global industry value added, personal consumption, expenditures, modern trade penetration and consumer price indices. The chapter also covers forecast factors - relevance & impact, value chain analysis and market dynamics (drivers, restraints and opportunities) to better understand the market.

Chapter 03 - Global USA Medical Coding Market Demand Analysis 2015-2022 and Forecast, 2023-2033

The chapter include historical market value (US$ 937.4 Million) analysis (2015-2022) and current and future market value (US$ 1.0 Billion) and volume (8.4%) projections (2023-2033). The projections are based on the Y-O-Y growth trend analysis and absolute $ opportunity analysis country of operation.

Chapter 04 - Global USA Medical Coding Market - Pricing Analysis

Based on By Clinical Specialties, the pricing analysis chapter include Regional pricing analysis (USD/MT), global average pricing analysis benchmark, and key factors impacting the pricing.

Chapter 05 - Global USA Medical Coding Market Analysis 2015-2022 and Forecast 2023-2033, By Clinical Specialties

Based on By Clinical Specialties, USA Medical Coding Market is segmented into Emergency Medicine, Diagnostic Pathology Services, Diagnostic Imaging (Radiology Imaging, Interventional Radiology, Nuclear Medicine), Inpatient Treatment (Radiology Imaging, Interventional Radiology, Nuclear Medicine, Anaesthesia and Critical Care, Cardiology & Cardiac Surgery, Gastroenterology & Hepatology, Obstetrics and Gynecology, Nephrology, Urology, Neurology & Neurosurgery, General Surgery, Orthopedics, Spinal and Pulmonology, Reproductive Medicine, Rheumatology, Dental Sciences & Cranio-Maxillo Facial Surgery, Oncology, Diabetology & Endocrinology, Pediatrics & Neonatology, Psychiatry & Clinical Psychology, Organ Transplant), Outpatient Treatment & Diagnostics, Ophthalmology, Dermatology, ENT, Clinical Nutrition, Ambulatory Surgery, Physician Office Visits, Ancillary Services, Observation Services, Others. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By Clinical Specialties.

Chapter 06 - Global USA Medical Coding Market Analysis 2015-2022 and Forecast 2023-2033, By Service

Based on By Service, USA Medical Coding Market is segmented into In-house, Outsourced. This section also offers market attractiveness analysis based on By Service. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By Service.

Chapter 07 - Global USA Medical Coding Market Analysis 2015-2022 and Forecast 2023-2033, By End User

Based on By End User, USA Medical Coding Market is segmented into Enterprise Therapy Practices (Hospitals, Ambulatory Surgical Centers, Cancer Research Institutes, Long Term Care Centers, Small Therapy Practices (Specialty Clinics, Independent Physician Practices), Diagnostic & Reference Laboratories, Diagnostic Imaging Centers, Educational & Research Institutes, Healthcare Payers, EMS Services, Health Services. This section also offers market attractiveness analysis based on By End User. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By End User.

Chapter 08 - USA Medical Coding Market Analysis 2015-2022 and Forecast 2023-2033, By Region

Based on By Region, USA Medical Coding Market is segmented into Northeast USA, Midwest USA, Southeast USA, Southwest USA, West USA. This section also offers market attractiveness analysis based on By Region. Readers can also find value forecast and Y-o-Y growth comparison for all above mentioned By Region.

Chapter 09 - Key Countries USA Medical Coding Market Analysis 2015-2022 and Forecast 2023-2033

This chapter offers insights into how the USA Medical Coding Market is expected to grow in major countries globally.

Chapter 10 - Market Structure Analysis- Global Assessment

This chapter includes company dashboard, industry structure analysis by tier of companies, 2022E, company share analysis of top players, 2022E, and competition benchmarking- matrix.

Chapter 11 - Competition Deep Dive (Tentative List)

This chapter includes company overview, By Clinical Specialties portfolio of companies, profitability by market segments, sales footprint, SWOT analysis and strategy overview of the companies being studied in the report. Some of the market players featured in the report are Tebra (Kareo, Inc.), Global Payments, Inc. (AdvancedMD, Inc.), EverCommerce Inc. (DrChrono Inc.), The 3M Company (3M Health Information Systems, Inc.), Greenway Health, LLC, Dolbey, GeBBS Healthcare Solutions (Aviacode Inc.), AQuity, Baruch Business Solutions, Infinx, athenahealth, Inc., BUDDI.AI, Context4 Healthcare, Inc., Eclat Health Solutions Inc., Maverick Medical AI Ltd., UnitedHealth Group Inc. (Optum, Inc.), NYM, Practolytics, Outsource Strategies International, Datavant (Ciox), PCS (Precyse Coding Solutions, LLC), Novigo Health Care Services, I-conic Solutions.

Chapter 12 - Assumptions and Acronyms

This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the Vehicle Radar Test System report.

Chapter 13 - Research Methodology

This chapter helps readers understand the research methodology followed to obtain various conclusions, as well as important qualitative and quantitative information, on USA Medical Coding Market.


1. Executive Summary | USA Medical Coding Market
1.1. USA Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusion and Exclusion
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Service Innovation / Development Trends
4. Value Added Insights
4.1. USA Healthcare Regulatory Timeline
4.2. The USA Healthcare Ecosystem
4.3. Medical Coding Outsourcing Services Spectrum
4.4. Medical and Risk Adjusted Coding Value Chain
4.5. Evolution of Healthcare Outsourcing Model
4.6. PESTEL Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Healthcare IT Spending Outlook, By USA & Global
5.1.2. USA per-Capita Healthcare Expenditure
5.2. Forecast Factors - Relevance & Impact
5.2.1. Government Initiatives to Encourage Healthcare IT usage
5.2.2. Introduction to Technologically Advanced Healthcare Services
5.2.3. Significant Shift towards Computer-Assisted Coding Platforms
5.2.4. Increased Demand for Centralizing and Streamlining Healthcare Workflow
5.2.5. Increasing Spending on Research and Development
5.2.6. Top Players Historical Growth
5.2.7. Reduction in Errors
5.2.8. Rise in Adoption of Medical Coding Services
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID-19 Crisis Analysis
6.1. COVID-19 Impact Analysis
6.1.1. By Clinical Specialties
6.1.2. By Service
6.1.3. By End User
6.1.4. By Region
6.2. COVID-19 Impact on Market
7. USA Market - Pricing Analysis
7.1. Market Pricing Analysis (Generic Pricing), By Clinical Specialties, 2022
7.2. Market Pricing Analysis (FTE (Full Time Equivalent) Pricing), By Clinical Specialties, 2022
8. USA Market Demand (in Value US$ Million) Analysis 2015 to 2022 and Forecast, 2023 to 2033
8.1. Historical Market Value (US$ Million) Analysis, 2015 to 2022
8.2. Current and Future Market Value (US$ Million) Projections, 2023 to 2033
8.2.1. Y-o-Y Growth Trend Analysis
8.2.2. Absolute $ Opportunity Analysis
9. USA Market Analysis 2015 to 2022 and Forecast 2023 to 2033, By Clinical Specialties
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Million) Analysis By Clinical Specialties, 2015 to 2022
9.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Clinical Specialties, 2023 to 2033
9.3.1. Emergency Medicine
9.3.2. Diagnostic Pathology Services
9.3.3. Diagnostic Imaging
9.3.3.1. Radiology Imaging
9.3.3.2. Interventional Radiology
9.3.3.3. Nuclear Medicine
9.3.4. Inpatient Treatment
9.3.4.1. Anaesthesia and Critical Care
9.3.4.2. Cardiology & Cardiac Surgery
9.3.4.3. Gastroenterology & Hepatology
9.3.4.4. Obstetrics and Gynecology
9.3.4.5. Nephrology
9.3.4.6. Urology
9.3.4.7. Neurology & Neurosurgery
9.3.4.8. General Surgery
9.3.4.9. Orthopedics
9.3.4.10. Spinal and Pulmonology
9.3.4.11. Reproductive Medicine
9.3.4.12. Rheumatology
9.3.4.13. Dental Sciences & Cranio-Maxillo Facial Surgery
9.3.4.14. Oncology
9.3.4.15. Diabetology & Endocrinology
9.3.4.16. Pediatrics & Neonatology
9.3.4.17. Psychiatry & Clinical Psychology
9.3.4.18. Organ Transplant
9.3.5. Hospital Outpatient Treatment & Diagnostics
9.3.6. Ophthalmology
9.3.7. Dermatology
9.3.8. ENT
9.3.9. Clinical Nutrition
9.3.10. Ambulatory Surgery
9.3.11. Physician Office Visits
9.3.12. Ancillary Services
9.3.13. Observation Services
9.3.14. Others
9.4. Market Attractiveness Analysis By Clinical Specialties
10. USA Market Analysis 2015 to 2022 and Forecast 2023 to 2033, by Service
10.1. Introduction
10.2. Historical Market Size (US$ Million) Analysis by Service, 2015 to 2022
10.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Service, 2023 to 2033
10.3.1. In-house
10.3.2. Outsourced
10.4. Market Attractiveness Analysis by Service
11. USA Market Analysis 2015 to 2022 and Forecast 2023 to 2033, By End User
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Million) Analysis By End User, 2015 to 2022
11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End User, 2023 to 2033
11.3.1. Enterprise Therapy Practices
11.3.1.1. Hospitals
11.3.1.2. Ambulatory Surgical Centers
11.3.1.3. Cancer Research Institutes
11.3.1.4. Long Term Care Centers
11.3.2. Small Therapy Practices
11.3.2.1. Specialty Clinics
11.3.2.2. Independent Physician Practices
11.3.3. Diagnostic & Reference Laboratories
11.3.4. Diagnostic Imaging Centers
11.3.5. Educational & Research Institutes
11.3.6. Healthcare Payers
11.3.7. EMS Services
11.3.8. Health Services
11.4. Market Attractiveness Analysis By End User
12. USA Market Analysis 2015 to 2022 and Forecast 2023 to 2033, by Region
12.1. Introduction
12.2. Historical Market Size (US$ Million) Analysis by Region, 2015 to 2022
12.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Region, 2023 to 2033
12.3.1. Northeast USA
12.3.2. Midwest USA
12.3.3. Southeast USA
12.3.4. Southwest USA
12.3.5. West USA
12.4. Market Attractiveness Analysis by Region
13. Northeast USA Market Analysis 2015 to 2022 and Forecast 2023 to 2033
13.1. Introduction
13.2. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2015 to 2022
13.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2022 - 2032
13.3.1. By States
13.3.1.1. New York
13.3.1.2. New Jersey
13.3.1.3. Massachusetts
13.3.1.4. Rest of Northeast USA
13.3.2. By Clinical Specialties
13.3.3. By Service
13.3.4. By End User
13.4. Market Attractiveness Analysis
13.4.1. By States
13.4.2. By Clinical Specialties
13.4.3. By Service
13.4.4. By End User
13.5. Market Trends
13.6. Key Market Participants - Intensity Mapping
13.7. Drivers and Restraints - Impact Analysis
14. Midwest USA Market Analysis 2015 to 2022 and Forecast 2023 to 2033
14.1. Introduction
14.2. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2015 to 2022
14.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2022 - 2032
14.3.1. By States
14.3.1.1. Wisconsin
14.3.1.2. Minnesota
14.3.1.3. Rest of Midwest USA
14.3.2. By Clinical Specialties
14.3.3. By Service
14.3.4. By End User
14.4. Market Attractiveness Analysis
14.4.1. By States
14.4.2. By Clinical Specialties
14.4.3. By Service
14.4.4. By End User
14.5. Market Trends
14.6. Key Market Participants - Intensity Mapping
14.7. Drivers and Restraints - Impact Analysis
15. Southeast USA Market Analysis 2015 to 2022 and Forecast 2023 to 2033
15.1. Introduction
15.2. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2015 to 2022
15.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2022 - 2032
15.3.1. By States
15.3.1.1. North Carolina
15.3.1.2. South Carolina
15.3.1.3. Florida
15.3.1.4. Virginia
15.3.1.5. Rest of Southeast USA
15.3.2. By Clinical Specialties
15.3.3. By Service
15.3.4. By End User
15.4. Market Attractiveness Analysis
15.4.1. By States
15.4.2. By Clinical Specialties
15.4.3. By Service
15.4.4. By End User
15.5. Market Trends
15.6. Key Market Participants - Intensity Mapping
15.7. Drivers and Restraints - Impact Analysis
16. Southwest USA Market Analysis 2015 to 2022 and Forecast 2023 to 2033
16.1. Introduction
16.2. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2015 to 2022
16.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2022 - 2032
16.3.1. By States
16.3.1.1. Louisiana
16.3.1.2. Oklahoma
16.3.1.3. Texas
16.3.1.4. Rest of Southeast USA
16.3.2. By Clinical Specialties
16.3.3. By Service
16.3.4. By End User
16.4. Market Attractiveness Analysis
16.4.1. By States
16.4.2. By Clinical Specialties
16.4.3. By Service
16.4.4. By End User
16.5. Market Trends
16.6. Key Market Participants - Intensity Mapping
16.7. Drivers and Restraints - Impact Analysis
17. West USA Market Analysis 2015 to 2022 and Forecast 2023 to 2033
17.1. Introduction
17.2. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2015 to 2022
17.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2022 to 2032
17.3.1. By States
17.3.1.1. Washington
17.3.1.2. California
17.3.1.3. New Mexico
17.3.1.4. Rest of West USA
17.3.2. By Clinical Specialties
17.3.3. By Service
17.3.4. By End User
17.4. Market Attractiveness Analysis
17.4.1. By States
17.4.2. By Clinical Specialties
17.4.3. By Service
17.4.4. By End User
17.5. Market Trends
17.6. Key Market Participants - Intensity Mapping
17.7. Drivers and Restraints - Impact Analysis
18. Competition Analysis
18.1. Competition Dashboard
18.2. Competition Benchmarking
18.3. Competition Deep Dive
Software Vendors:
18.3.1. Tebra (Kareo, Inc.)
18.3.1.1. Overview
18.3.1.2. Solution Portfolio
18.3.1.3. Key Financial
18.3.1.4. Sales Footprint
18.3.1.5. SWOT Analysis
18.3.1.6. Strategy Overview
18.3.1.6.1. Marketing Strategy
18.3.1.6.2. Product Strategy
18.3.1.6.3. Channel Strategy
18.3.2. Global Payments, Inc. (AdvancedMD, Inc.)
18.3.2.1. Overview
18.3.2.2. Solution Portfolio
18.3.2.3. Key Financial
18.3.2.4. Sales Footprint
18.3.2.5. SWOT Analysis
18.3.2.6. Strategy Overview
18.3.2.6.1. Marketing Strategy
18.3.2.6.2. Product Strategy
18.3.2.6.3. Channel Strategy
18.3.3. EverCommerce Inc. (DrChrono Inc.)
18.3.3.1. Overview
18.3.3.2. Solution Portfolio
18.3.3.3. Key Financial
18.3.3.4. Sales Footprint
18.3.3.5. SWOT Analysis
18.3.3.6. Strategy Overview
18.3.3.6.1. Marketing Strategy
18.3.3.6.2. Product Strategy
18.3.3.6.3. Channel Strategy
18.3.4. The 3M Company (3M Health Information Systems, Inc.)
18.3.4.1. Overview
18.3.4.2. Solution Portfolio
18.3.4.3. Key Financial
18.3.4.4. Sales Footprint
18.3.4.5. SWOT Analysis
18.3.4.6. Strategy Overview
18.3.4.6.1. Marketing Strategy
18.3.4.6.2. Product Strategy
18.3.4.6.3. Channel Strategy
18.3.5. Greenway Health, LLC
18.3.5.1. Overview
18.3.5.2. Solution Portfolio
18.3.5.3. Key Financial
18.3.5.4. Sales Footprint
18.3.5.5. SWOT Analysis
18.3.5.6. Strategy Overview
18.3.5.6.1. Marketing Strategy
18.3.5.6.2. Product Strategy
18.3.5.6.3. Channel Strategy
18.3.6. Dolbey
18.3.6.1. Overview
18.3.6.2. Solution Portfolio
18.3.6.3. Key Financial
18.3.6.4. Sales Footprint
18.3.6.5. SWOT Analysis
18.3.6.6. Strategy Overview
18.3.6.6.1. Marketing Strategy
18.3.6.6.2. Product Strategy
18.3.6.6.3. Channel Strategy
18.3.7. GeBBS Healthcare Solutions (Aviacode Inc.)
18.3.7.1. Overview
18.3.7.2. Solution Portfolio
18.3.7.3. Key Financial
18.3.7.4. Sales Footprint
18.3.7.5. SWOT Analysis
18.3.7.6. Strategy Overview
18.3.7.6.1. Marketing Strategy
18.3.7.6.2. Product Strategy
18.3.7.6.3. Channel Strategy
18.3.8. AQuity
18.3.8.1. Overview
18.3.8.2. Solution Portfolio
18.3.8.3. Key Financial
18.3.8.4. Sales Footprint
18.3.8.5. SWOT Analysis
18.3.8.6. Strategy Overview
18.3.8.6.1. Marketing Strategy
18.3.8.6.2. Product Strategy
18.3.8.6.3. Channel Strategy
18.3.9. Baruch Business Solutions
18.3.9.1. Overview
18.3.9.2. Solution Portfolio
18.3.9.3. Key Financial
18.3.9.4. Sales Footprint
18.3.9.5. SWOT Analysis
18.3.9.6. Strategy Overview
18.3.9.6.1. Marketing Strategy
18.3.9.6.2. Product Strategy
18.3.9.6.3. Channel Strategy
18.3.10. Infinx
18.3.10.1. Overview
18.3.10.2. Solution Portfolio
18.3.10.3. Key Financial
18.3.10.4. Sales Footprint
18.3.10.5. SWOT Analysis
18.3.10.6. Strategy Overview
18.3.10.6.1. Marketing Strategy
18.3.10.6.2. Product Strategy
18.3.10.6.3. Channel Strategy
18.3.11. athenahealth, Inc.
18.3.11.1. Overview
18.3.11.2. Solution Portfolio
18.3.11.3. Key Financial
18.3.11.4. Sales Footprint
18.3.11.5. SWOT Analysis
18.3.11.6. Strategy Overview
18.3.11.6.1. Marketing Strategy
18.3.11.6.2. Product Strategy
18.3.11.6.3. Channel Strategy
18.3.12. BUDDI.AI
18.3.12.1. Overview
18.3.12.2. Solution Portfolio
18.3.12.3. Key Financial
18.3.12.4. Sales Footprint
18.3.12.5. SWOT Analysis
18.3.12.6. Strategy Overview
18.3.12.6.1. Marketing Strategy
18.3.12.6.2. Product Strategy
18.3.12.6.3. Channel Strategy
18.3.13. Context4 Healthcare, Inc.
18.3.13.1. Overview
18.3.13.2. Solution Portfolio
18.3.13.3. Key Financial
18.3.13.4. Sales Footprint
18.3.13.5. SWOT Analysis
18.3.13.6. Strategy Overview
18.3.13.6.1. Marketing Strategy
18.3.13.6.2. Product Strategy
18.3.13.6.3. Channel Strategy
18.3.14. Eclat Health Solutions Inc.
18.3.14.1. Overview
18.3.14.2. Solution Portfolio
18.3.14.3. Key Financial
18.3.14.4. Sales Footprint
18.3.14.5. SWOT Analysis
18.3.14.6. Strategy Overview
18.3.14.6.1. Marketing Strategy
18.3.14.6.2. Product Strategy
18.3.14.6.3. Channel Strategy
18.3.15. Maverick Medical AI Ltd.
18.3.15.1. Overview
18.3.15.2. Solution Portfolio
18.3.15.3. Key Financial
18.3.15.4. Sales Footprint
18.3.15.5. SWOT Analysis
18.3.15.6. Strategy Overview
18.3.15.6.1. Marketing Strategy
18.3.15.6.2. Product Strategy
18.3.15.6.3. Channel Strategy
18.3.16. UnitedHealth Group Inc. (Optum, Inc.)
18.3.16.1. Overview
18.3.16.2. Solution Portfolio
18.3.16.3. Key Financial
18.3.16.4. Sales Footprint
18.3.16.5. SWOT Analysis
18.3.16.6. Strategy Overview
18.3.16.6.1. Marketing Strategy
18.3.16.6.2. Product Strategy
18.3.16.6.3. Channel Strategy
18.3.17. NYM 
18.3.17.1. Overview
18.3.17.2. Solution Portfolio
18.3.17.3. Key Financial
18.3.17.4. Sales Footprint
18.3.17.5. SWOT Analysis
18.3.17.6. Strategy Overview
18.3.17.6.1. Marketing Strategy
18.3.17.6.2. Product Strategy
18.3.17.6.3. Channel Strategy
Services Providers:
18.3.18. Practolytics
18.3.18.1. Overview
18.3.18.2. Solution Portfolio
18.3.18.3. Key Financial
18.3.18.4. Sales Footprint
18.3.18.5. SWOT Analysis
18.3.18.6. Strategy Overview
18.3.18.6.1. Marketing Strategy
18.3.18.6.2. Product Strategy
18.3.18.6.3. Channel Strategy
18.3.19. Outsource Strategies International
18.3.19.1. Overview
18.3.19.2. Solution Portfolio
18.3.19.3. Key Financial
18.3.19.4. Sales Footprint
18.3.19.5. SWOT Analysis
18.3.19.6. Strategy Overview
18.3.19.6.1. Marketing Strategy
18.3.19.6.2. Product Strategy
18.3.19.6.3. Channel Strategy
18.3.20. Datavant (Ciox)
18.3.20.1. Overview
18.3.20.2. Solution Portfolio
18.3.20.3. Key Financial
18.3.20.4. Sales Footprint
18.3.20.5. SWOT Analysis
18.3.20.6. Strategy Overview
18.3.20.6.1. Marketing Strategy
18.3.20.6.2. Product Strategy
18.3.20.6.3. Channel Strategy
18.3.21. PCS (Precyse Coding Solutions, LLC)
18.3.21.1. Overview
18.3.21.2. Solution Portfolio
18.3.21.3. Key Financial
18.3.21.4. Sales Footprint
18.3.21.5. SWOT Analysis
18.3.21.6. Strategy Overview
18.3.21.6.1. Marketing Strategy
18.3.21.6.2. Product Strategy
18.3.21.6.3. Channel Strategy
18.3.22. Novigo Health Care Services
18.3.22.1. Overview
18.3.22.2. Solution Portfolio
18.3.22.3. Key Financial
18.3.22.4. Sales Footprint
18.3.22.5. SWOT Analysis
18.3.22.6. Strategy Overview
18.3.22.6.1. Marketing Strategy
18.3.22.6.2. Product Strategy
18.3.22.6.3. Channel Strategy
18.3.23. I-conic Solutions
18.3.23.1. Overview
18.3.23.2. Solution Portfolio
18.3.23.3. Key Financial
18.3.23.4. Sales Footprint
18.3.23.5. SWOT Analysis
18.3.23.6. Strategy Overview
18.3.23.6.1. Marketing Strategy
18.3.23.6.2. Product Strategy
18.3.23.6.3. Channel Strategy
19. Assumptions and Acronyms Used
20. Research Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings